Paper36944461
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.
van den Bosch CH and 8 others. BMJ Open, 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients. Papers, record 36944461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36944461
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Central Venous Catheters | Major topic |
| Catheter-Related Infections | Major topic |
| Sepsis | Major topic |
| Neoplasms | Major topic |
| Child | |
| Humans | |
| Heparin | |
| Citric Acid | |
| Quality of Life | |
| Citrates | |
| Randomized Controlled Trials as Topic | |
| Taurine | |
| Thiadiazines |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05740150 | Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients. | Derived from the trial | Yes |
Source ClinicalTrials.gov
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8664397 | Exact estimates for a rate ratio. | Epidemiology | 1996 | https://conductscience.org/library/papers/8664397 | PubMed |
| 2 | 34767871 | The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis. | J Hosp Infect | 2022 | https://conductscience.org/library/papers/34767871 | PubMed |
| 3 | 31145505 | Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates. | J Paediatr Child Health | 2020 | https://conductscience.org/library/papers/31145505 | PubMed |
| 4 | 20126631 | Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall. | PLoS One | 2010 | https://conductscience.org/library/papers/20126631 | PubMed |
| 5 | 26459655 | Complications of Central Venous Access Devices: A Systematic Review. | Pediatrics | 2015 | https://conductscience.org/library/papers/26459655 | PubMed |
| 6 | 18664278 | Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. | BMC Infect Dis | 2008 | https://conductscience.org/library/papers/18664278 | PubMed |
| 7 | 30415957 | Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center study. | J Pediatr Surg | 2019 | https://conductscience.org/library/papers/30415957 | PubMed |
| 8 | 24861410 | Microbiocidal effects of various taurolidine containing catheter lock solutions. | Clin Nutr | 2015 | https://conductscience.org/library/papers/24861410 | PubMed |
| 9 | 24841014 | Complications of total implantable access ports and efficacy of Taurolidine-citrate lock solution against catheter-related infections. | Afr J Paediatr Surg | 2014 | https://conductscience.org/library/papers/24841014 | PubMed |
| 10 | 22342714 | Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. | J Hosp Infect | 2012 | https://conductscience.org/library/papers/22342714 | PubMed |
| 11 | 27390716 | Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost- effectiveness analysis. | Med J Islam Repub Iran | 2016 | https://conductscience.org/library/papers/27390716 | PubMed |
| 12 | 23417891 | Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. | Pediatr Blood Cancer | 2013 | https://conductscience.org/library/papers/23417891 | PubMed |
| 13 | 23267744 | Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks. | Clin Nutr | 2013 | https://conductscience.org/library/papers/23267744 | PubMed |
| 14 | 1742385 | An efficient program for computing conditional maximum likelihood estimates and exact confidence limits for a common odds ratio. | Epidemiology | 1991 | https://conductscience.org/library/papers/1742385 | PubMed |
| 15 | 27516141 | Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus. | J Vasc Access | 2016 | https://conductscience.org/library/papers/27516141 | PubMed |
| 16 | 17031868 | Tutorial in biostatistics: competing risks and multi-state models. | Stat Med | 2007 | https://conductscience.org/library/papers/17031868 | PubMed |
| 17 | 23799867 | Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23799867 | PubMed |
| 18 | 3298185 | Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agent. | J Appl Bacteriol | 1987 | https://conductscience.org/library/papers/3298185 | PubMed |
| 19 | 30204661 | Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients. | Pediatr Infect Dis J | 2019 | https://conductscience.org/library/papers/30204661 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41254792 | Impact of TauroLock™-HEP500 versus unfractionated heparin for prevention of catheter complications in children with malignancy: a prospective, randomized, controlled study. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/41254792 | PubMed |
| 40005772 | Antimicrobial Lock Therapy in Clinical Practice: A Scoping Review. | Microorganisms | 2025 | https://conductscience.org/library/papers/40005772 | PubMed |
| 40001933 | Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40001933 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| LIPC | 3990 | PubTator's text mining | https://conductscience.org/library/genes/3990 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36944461
GET https://conductscience.org/api/papers/v1/36944461/authors